Values as of: 2024-10-21
ETF | Health |
Last Closing
USD 87.5Change
-1.19 (-1.34)%Market Cap
USD 0.22BVolume
5.80KAnalyst Target
N/AVerdict
Verdict
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).
Company Website : http://www.spdrs.com
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| XLV | Health Care Select Sector SPDR.. |
-1.80 (-1.18%) |
USD 41.35B |
| FHLC | Fidelity® MSCI Health Care In.. |
-0.85 (-1.17%) |
USD 2.95B |
| FXH | First Trust Health Care AlphaD.. |
-1.37 (-1.24%) |
USD 1.22B |
| IDNA | iShares Genomics Immunology an.. |
-0.39 (-1.58%) |
USD 0.14B |
| SBIO | ALPS Medical Breakthroughs ETF |
-0.71 (-1.78%) |
USD 0.12B |
| XHS | SPDR® S&P Health Care Service.. |
-1.52 (-1.58%) |
USD 0.08B |
| HTEC | Robo Global® Healthcare Techn.. |
-0.34 (-1.17%) |
USD 0.06B |
| BBP | Virtus LifeSci Biotech Product.. |
-0.76 (-1.20%) |
USD 0.02B |
| BBC | Virtus LifeSci Biotech Clinica.. |
-0.67 (-2.19%) |
USD 0.01B |
| IHE | iShares U.S. Pharmaceuticals E.. |
-1.05 (-1.46%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| INAV | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Health) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | -48.08% | 29% | F | 9% | A- | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -48.08% | 29% | F | 14% | F | ||
| Trailing 12 Months | |||||||
| Capital Gain | -37.46% | 38% | F | 10% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -37.46% | 38% | F | 15% | F | ||
| Trailing 5 Years | |||||||
| Capital Gain | -43.36% | 29% | F | 16% | F | ||
| Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
| Total Return | -43.36% | 29% | F | 22% | F | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 1.18% | 29% | F | 40% | F | ||
| Dividend Return | 1.19% | 24% | F | 30% | F | ||
| Total Return | 0.01% | 5% | F | 1% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 26.54% | 33% | F | 39% | F | ||
| Risk Adjusted Return | 4.49% | 29% | F | 25% | F | ||
| Market Capitalization | 0.22B | 70% | C- | 37% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
